{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Humacao",
      "state": "PR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA021436"
        ],
        "brand_name": [
          "ABILIFY"
        ],
        "generic_name": [
          "ARIPIPRAZOLE"
        ],
        "manufacturer_name": [
          "Otsuka America Pharmaceutical, Inc."
        ],
        "product_ndc": [
          "59148-006",
          "59148-007",
          "59148-008",
          "59148-009",
          "59148-010",
          "59148-011"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ARIPIPRAZOLE"
        ],
        "rxcui": [
          "349490",
          "349545",
          "349547",
          "349553",
          "352307",
          "352308",
          "352309",
          "352310",
          "402131",
          "404602",
          "602964",
          "615172"
        ],
        "spl_id": [
          "1b189d15-798d-4bed-a93d-a543ed7abd81"
        ],
        "spl_set_id": [
          "c040bd1d-45b7-49f2-93ea-aed7220b30ac"
        ],
        "package_ndc": [
          "59148-006-13",
          "59148-006-92",
          "59148-007-13",
          "59148-007-35",
          "59148-007-94",
          "59148-008-13",
          "59148-008-35",
          "59148-008-95",
          "59148-009-13",
          "59148-009-35",
          "59148-009-95",
          "59148-010-13",
          "59148-010-35",
          "59148-011-13",
          "59148-011-35"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175430"
        ],
        "pharm_class_epc": [
          "Atypical Antipsychotic [EPC]"
        ],
        "unii": [
          "82VFR53I78"
        ]
      },
      "product_type": "Drugs",
      "event_id": "63706",
      "recalling_firm": "Bristol Myers Squibb Manufacturing Company",
      "address_1": "Rd #3 Km 77.5",
      "address_2": "N/A",
      "postal_code": "00792",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "LA, TN, CA",
      "recall_number": "D-181-2013",
      "product_description": "ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35",
      "product_quantity": "21 blister packs",
      "reason_for_recall": "CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.",
      "recall_initiation_date": "20121102",
      "center_classification_date": "20130304",
      "termination_date": "20130502",
      "report_date": "20130313",
      "code_info": "2E69023A, Exp. FEB 28 2015"
    }
  ]
}